F-group (family)
107.1.1.2 Cytochrom_C1
Ligands and drugs
484
Member domains
416
with ligand contacts (≤ 4 Å)
86.0% of members
273
with DrugDomain annotations
56.4% of members
273
with a DrugBank compound
56.4% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 107.1.1.2 belongs to X-group 107 Cytochrome c-like, which binds 5.5 ligand superclasses per 20 proteins, narrower than 78% of the 256 X-groups with enough proteins to compare. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB03317 | HEC | Ferroheme C | 212 |
| DB18267 | HEM | Ferroheme | 60 |
| DB03152 | BGL | B-2-Octylglucoside | 16 |
| DB04327 | PEE | Phosphatidylethanolamine | 6 |
| DB01728 | PEF | 1,2-dihexadecanoyl-sn-glycero-3-phosphoethanolamine | 4 |
| DB03429 | CDL | Tetrastearoyl cardiolipin | 4 |
| DB02580 | PG6 | Pentaglyme | 1 |
| DB04141 | — | 2-Hexyloxy-6-Hydroxymethyl-Tetrahydro-Pyran-3,4,5-Triol | 1 |
| DB04799 | — | 6-Hydroxy-5-undecyl-4,7-benzothiazoledione | 1 |
| DB07401 | — | Azoxystrobin | 1 |
| DB07636 | — | 5-Heptyl-6-hydroxy-1,3-benzothiazole-4,7-dione | 1 |
| DB07763 | — | (5S)-3-ANILINO-5-(2,4-DIFLUOROPHENYL)-5-METHYL-1,3-OXAZOLIDINE-2,4-DIONE | 1 |
| DB07778 | — | (S)-famoxadone | 1 |
| DB08330 | — | METHYL (2Z)-3-METHOXY-2-{2-[(E)-2-PHENYLVINYL]PHENYL}ACRYLATE | 1 |
| DB08453 | — | 2-Nonyl-4-quinolinol 1-oxide | 1 |
| DB08690 | — | Ubiquinone Q2 | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| HEC | HEME C | 332 |
| HEM | PROTOPORPHYRIN IX CONTAINING FE | 71 |
| SRmetal | STRONTIUM ION | 36 |
| CDL | CARDIOLIPIN | 27 |
| 3PE | 1,2-Distearoyl-sn-glycerophosphoethanolamine | 24 |
| PC1 | 1,2-DIACYL-SN-GLYCERO-3-PHOSPHOCHOLINE | 23 |
| PEE | 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine | 19 |
| BGL | 2-O-octyl-beta-D-glucopyranose | 16 |
| PLX | (9R,11S)-9-({[(1S)-1-HYDROXYHEXADECYL]OXY}METHYL)-2,2-DIMETHYL-5,7,10-TRIOXA-2LAMBDA~5~-AZA-6LAMBDA~5~-PHOSPHAOCTACOSANE-6,6,11-TRIOL | 11 |
| 3PH | 1,2-DIACYL-GLYCEROL-3-SN-PHOSPHATE | 4 |
| AZI | AZIDE ION | 4 |
| PTY | PHOSPHATIDYLETHANOLAMINE | 4 |
| CAmetal | CALCIUM ION | 3 |
| 8SP | O-[(R)-{[(2R)-2,3-bis(octanoyloxy)propyl]oxy}(hydroxy)phosphoryl]-L-serine | 2 |
| DU0 | 2-[2-[(1~{S},2~{S},4~{S},5'~{R},6~{R},7~{S},8~{R},9~{S},12~{S},13~{R},16~{S})-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icos-18-ene-6,2'-oxane]-16-yl]oxyethyl]propane-1,3-diol | 2 |
| PEF | DI-PALMITOYL-3-SN-PHOSPHATIDYLETHANOLAMINE | 2 |
| PGT | (1S)-2-{[{[(2R)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL STEARATE | 2 |
| UNL | Unknown ligand | 2 |
| ZNmetal | ZINC ION | 2 |
| LOP | (1R)-2-{[(R)-(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(DODECANOYLOXY)METHYL]ETHYL (9Z)-OCTADEC-9-ENOATE | 1 |